journavx suzetrigine - Search News

FDA, Journavx

Hosted on MSN · 1h

FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,

Columbus Ledger-Enquirer (Ga.) … · 1h

FDA approves a new pain med that could eliminate addiction. When can GA patients get it?

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non-addictive alternative.

U.S. News & World Report · 2d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Sierra Sun Times6h

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New Approaches for Pain Management

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...

StudyFinds on MSN23h

Journavx: What to know about new FDA-approved non-opioid pain medication

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results